Bayesian penalised likelihood reconstruction (Q.Clear) of 18F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation

British Journal of Radiology - Tập 91 Số 1085 - 2018
Eugene Teoh1,2, Daniel R. McGowan2,3, David M. Schuster3, Maria Tsakok4, Fergus Gleeson1,4, Kevin M. Bradley4
1Department of Oncology, University of Oxford, Oxford, UK
2Department of Radiation Physics and Protection, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK
3Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA
4Department of Radiology, Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, UK

Tóm tắt

Objective: 18F-Fluciclovine (FACBC) is an amino acid PET radiotracer approved for recurrent prostate cancer imaging. We investigate the use of Bayesian penalised likelihood (BPL) reconstruction for 18F-fluciclovine PET. Methods: 15 18F-fluciclovine scans were reconstructed using ordered subset expectation maximisation (OSEM), OSEM + point spread function (PSF) modelling and BPL using β-values 100–600. Lesion maximum standardised uptake value (SUVmax), organ SUVmean and standard deviation were measured. Deidentified reconstructions (OSEM, PSF, BPL using β200–600) from 10 cases were visually analysed by two readers who indicated their most and least preferred reconstructions, and scored overall image quality, noise level, background marrow image quality and lesion conspicuity. Results: Comparing BPL to OSEM, there were significant increments in lesion SUVmax and signal-to-background up to β400, with highest gain in β100 reconstructions (mean ΔSUVmax 3.9, p < 0.0001). Organ noise levels increased on PSF, β100 and β200 reconstructions. Across BPL reconstructions, there was incremental reduction in organ noise with increasing β, statistically significant beyond β300–500 (organ-dependent). Comparing with OSEM and PSF, lesion signal-to-noise was significantly increased in BPL reconstructions where β ≥ 300 and  ≥ 200 respectively. On visual analysis, β 300 had the first and second highest scores for image quality, β500 and β600 equal highest scores for marrow image quality and least noise, PSF and β 200 had first and second highest scores for lesion conspicuity. For overall preference, one reader preferred β 300 in 9/10 cases and the other preferred β 200 in all cases. Conclusion: BPL reconstruction of 18F-fluciclovine PET images improves signal-to-noise ratio, affirmed by overall reader preferences. On balance, β300 is suggested for 18F-fluciclovine whole body PET image reconstruction using BPL. Advances in knowledge: The optimum β is different to that previously published for 18F-fluorodeoxyglucose, and has practical implications for a relatively new tracer in an environment with modern reconstruction technologies.

Từ khóa


Tài liệu tham khảo

Teoh, 2015, Phantom and clinical evaluation of the bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system, J Nucl Med, 56, 1447, 10.2967/jnumed.115.159301

Teoh, 2016, Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules, Eur Radiol, 26, 576, 10.1007/s00330-015-3832-y

Teoh, 2016, 18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction, Eur Radiol, 26, 4098, 10.1007/s00330-016-4253-2

Parvizi, 2015, Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?, Eur J Radiol, 84, 1873, 10.1016/j.ejrad.2015.06.025

Howard, 2017, Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT, Ann Nucl Med, 31, 623, 10.1007/s12149-017-1192-1

U.S. Food and Drug Administration . FDA approves new diagnostic imaging agent to detect recurrent prostate cancer . 2016 U.S. Food and Drug Administration website. Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm503920.htm. [ 19 May 2017 ]

European Medicines Agency . CHMP summary of positive opinion for Axumin . 2017 . Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500224397&mid=WC0b01ac058009a3dc [ cited 2017 19 May 2017 ]

Wollenweber, 2002, Parameterization of a model-based 3-D PET scatter correction, IEEE Trans Nucl Sci, 49, 722, 10.1109/TNS.2002.1039554

Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310

Rahmim, 2013, Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls, Med Phys, 40, 064301, 10.1118/1.4800806

Miller, 2017, Reader training for the restaging of biochemically recurrent prostate cancer using 18F-fluciclovine PET/CT, J Nucl Med, 58, 1596, 10.2967/jnumed.116.188375

Bach-Gansmo, 2017, Multisite experience of the safety, detection rate and diagnostic performance of fluciclovine (18F) positron emission tomography/computerized tomography imaging in the staging of biochemically recurrent prostate cancer, J Urol, 197, 676, 10.1016/j.juro.2016.09.117

Oka, 2014, Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose, Mol Imaging Biol, 16, 322, 10.1007/s11307-013-0693-0

Amzat, 2013, Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions, Mol Imaging Biol, 15, 633, 10.1007/s11307-012-0606-7

Tade, 2016, Anti-3-18F-FACBC (18F-fluciclovine) PET/CT of breast cancer: an exploratory study, J Nucl Med, 57, 1357, 10.2967/jnumed.115.171389

Thông tin
Thông tin xuất bản

British Journal of Radiology

Tập 91 Số 1085

Thông tin tác giả